Innate Pharma annual operating expenses
2017
2018
2019
2020
2021
2022
2023
2024
2025
Innate Pharma Operating Expenses Growth & History (IPH)
Innate Pharma's operating expenses was €63.0M for fiscal 2025.
View full Innate Pharma company overviewInnate Pharma annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €63.0M | −€8.7M | −12.11% |
| 2024 | 2024-12-31 | €71.7M | −€2.6M | −3.52% |
| 2023 | 2023-12-31 | €74.3M | €211,000 | +0.28% |
| 2022 | 2022-12-31 | €74.1M | €1.6M | +2.17% |
| 2021 | 2021-12-31 | €72.5M | €3.8M | +5.58% |
| 2020 | 2020-12-31 | €68.7M | −€36.0M | −34.36% |
| 2019 | 2019-12-31 | €104.6M | €16.9M | +19.33% |
| 2018 | 2018-12-31 | €87.7M | €3.7M | +4.38% |
| 2017 | 2017-12-31 | €84.0M | — | — |
Innate Pharma operating expenses trends
Over the last five fiscal years, Innate Pharma's operating expenses decreased from €68.7M to €63.0M, a change of −€5.7M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Innate Pharma source filings ↗